Nick Arab, Pattern Bioscience CEO
Pattern Bioscience raises $28.7M Series C for faster, more efficient antibiotic resistance test
The team at Pattern Bioscience is working on a test that can diagnose drug-resistant bacterial infections and identify effective antibiotics within hours, far faster than …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.